PDMR/Director Dealings & Holding(s) in Company

RNS Number : 9517J

EKF Diagnostics Holdings PLC

03 May 2022

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

PDMR/Director Dealings

& Holding(s) in Company

EKF, the AIM-listed global diagnostics business, announces that the Board of EKF has been informed that on Thursday 28 April 2022, certain funds connected to Christopher Mills, Non-executive Chairman, purchased a total of 1,275,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 35 pence per Ordinary Share.

Following this transaction, Christopher Mills' total direct and indirect interest in the Company is 132,150,000 Ordinary Shares, representing approximately 29.04% of the total voting rights over the Company's issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below as is the Standard form for notification of major holdings received by EKF today.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers")
2	Reason for the notification
a)	Position/status	Christopher Mills is the non-executive Chairman of the issuer and Chief Executive of the Investment Managers
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	EKF Diagnostics Holdings plc
b)	LEI	213800DXTF3EAUK1AR05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 1 pence each
	Identification code	GB0031509804
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			0.35	1,275,000
d)	Aggregated information
	- Aggregated volume	N/A single transaction
	- Price
e)	Date of the transaction	28 April 2022
f)	Place of the transaction	London Stock Exchange, AIMX

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:			EKF DIAGNOSTICS HOLDINGS PLC
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
Name			Harwood Capital Investment Management (Gibraltar) Limited
City and country of registered office (if applicable)			Gibraltar
4. Full name of shareholder(s) (if different from 3.) v
Name			Harwood Capital LLP North Atlantic Smaller Companies Investment Trust Plc Oryx International Growth Fund Limited
City and country of registered office (if applicable)			London, United Kingdom London, United Kingdom Guernsey, Guernsey
5. Date on which the threshold was crossed or reached vi:			28/04/2022
6. Date on which issuer notified (DD/MM/YYYY):			29/04/2022
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached	29.04	0.00		29.04	132,150,000
Position of previous notification (if applicable)	28.76	0.00		28.76

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ix					% of voting rights
		Direct (DTR5.1)		Indirect  (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB0031509804		150,000					0.03
GB0031509804		96,000,000					21.10
GB0031509804		36,000,000					7.91
SUBTOTAL 8. A		132,150,000					29.04%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date x	Exercise/ Conversion Period xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date x		Exercise/ Conversion Period xi		Physical or cash Settlement xii			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv				X
Name xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Christopher Harwood Bernard Mills (Harwood Capital LLP)	0.03
Christopher Harwood Bernard Mills (North Atlantic Smaller Companies Investment Trust plc)	21.10
Christopher Harwood Bernard Mills (Oryx International Growth Fund Limited)	7.91
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi

Place of completion	London Stock Exchange
Date of completion	28 April 2022

 

END

 

 

DSHBLGDSGXDDGDC